Fluorokines™ For Immuno-Oncology Research

For quality, consistency and high specificity in your research, try our wide selection of fluorescent-labeled recombinant protein Fluorokines™.

Immune checkpoint proteins help to regulate immune system activity, however tumor cells can evade the immune system by overexpressing certain checkpoint ligand proteins. This complication has led to the investigation of immunotherapies that target immune checkpoint proteins. These immunotherapies for the best-studied checkpoint proteins have shown remarkable results in certain patients. However, the efficacy of these treatments can vary or decline over time. It is important to develop tools to study the range of immune checkpoint proteins, which will help to improve the development and effectiveness of immunotherapies for cancer.

Determine which Fluorokine Checkpoint ligand will work best with the protein of your choice to offer great photostability, high specificity, and bioactivity for your immunotherapy experiments.